Maharashtra, India

Swati Kulkarni

This inventor holds 1 USPTO granted patent. Top assignee: Journey Medical Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Swati Kulkarni. Retrieved from https://idiyas.com/inventor/swati-kulkarni-3y6jgyp2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Swati Kulkarni: Innovator in Dermatological Treatments

Introduction

Swati Kulkarni is a prominent inventor based in Maharashtra, India. She has made significant contributions to the field of dermatology, particularly in the treatment of inflammatory skin conditions. Her innovative approach has led to the development of a unique pharmaceutical method that addresses these medical challenges effectively.

Latest Patents

Swati Kulkarni holds a patent for her invention titled "Methods for treating inflammatory skin conditions." This patent describes a method of treating such conditions by administering a pharmaceutical composition that includes a reduced dose of minocycline. The administration of this composition is designed to provide an effective plasma or interstitial fluid concentration of minocycline, which is crucial for treating inflammatory skin conditions. She has 1 patent to her name.

Career Highlights

Swati Kulkarni is associated with Journey Medical Corporation, where she continues to work on innovative solutions in dermatology. Her dedication to research and development has positioned her as a key player in her field.

Collaborations

Some of her notable coworkers include Bijay Kumar Padhi and Shanvas Alikunju, who contribute to her projects and research endeavors.

Conclusion

Swati Kulkarni's work in developing methods for treating inflammatory skin conditions showcases her commitment to advancing medical science. Her innovative contributions are paving the way for more effective treatments in dermatology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…